Testing a new neuroprotective treatment for sudden vision loss from optic nerve inflammation

This study is testing a new medication called privosegtor to see if it can help protect the optic nerve and improve vision recovery in people who have recently experienced optic neuritis—sudden inflammation of the nerve that carries vision from the eye to the brain. You would receive either the new medication plus standard steroid treatment, or a placebo plus the same standard steroid treatment. Researchers want to know if adding this treatment helps people see better and recover more quickly.

Optic neuritis can cause sudden, severe vision loss, and while steroid treatment is standard care, it doesn't work well enough for everyone. This trial aims to find out whether this medication could provide additional protection to the optic nerve and help more patients regain their vision.